These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
228 related items for PubMed ID: 8323415
1. Cardiovascular effects of OPC-13340, a potent, long-acting 1,4-dihydropyridine calcium channel blocker, in dogs. Mori T, Nakayama N, Ohura M, Ikezono K, Kinoshita S, Kamata M, Hosokawa T, Yamashita S, Yabuuchi Y. Arch Int Pharmacodyn Ther; 1993; 321():41-56. PubMed ID: 8323415 [Abstract] [Full Text] [Related]
2. Effects of the new dihydropyridine derivative 1,4-dihydro-2,6-dimethyl-4-(3-nitrophenyl)-3,5-pyridinedicarboxylic acid methyl 6-(5-phenyl-3-pyrazolyloxy)hexyl ester on the cardiohemodynamics and the energy metabolism of ischemic myocardium. Imai H, Matsui K, Ochi S, Nakazawa M, Nakagawa Y, Imai S. Arzneimittelforschung; 1987 Dec; 37(12):1348-52. PubMed ID: 3449062 [Abstract] [Full Text] [Related]
3. Hemodynamic effects of a dihydropyridine calcium antagonist, NB-818 (NPK-1886) in anesthetized dogs. Nishikibe M, Nagura J, Kamei K, Fukuroda T. Arch Int Pharmacodyn Ther; 1988 Dec; 291():7-20. PubMed ID: 3365068 [Abstract] [Full Text] [Related]
4. Comparative effects of the calcium antagonist isradipine and some other dihydropyridine derivatives on regional blood flow in anesthetized open-chest dogs. Sakanashi M, Noguchi K, Miyamoto Y, Kato T, Nagamine F, Yu WY, Higuchi M, Nakasone J. Arch Int Pharmacodyn Ther; 1988 Dec; 294():159-74. PubMed ID: 2976588 [Abstract] [Full Text] [Related]
5. [Vasodilator effects of LF 2.0254, a new 1,4-dihydropyridine. Comparison with nifedipine]. Pruneau D, Roy F, Brown NL. Therapie; 1989 Dec; 44(3):203-8. PubMed ID: 2781506 [Abstract] [Full Text] [Related]
11. Cardiovascular profile of RWJ 29009, a new potassium channel activator, in anesthetized and conscious dogs. Damiano BP, Giardino EC, Haertlein BJ, Stump GL, Mitchell JA, Falotico R. J Cardiovasc Pharmacol; 1994 Feb; 23(2):300-10. PubMed ID: 7511761 [Abstract] [Full Text] [Related]
12. Effects of niguldipine, a new dihydropyridine calcium antagonist, on regional blood flow, cardiac performance and myocardial metabolism in anaesthetized open-chest dogs. Fischer G, Schneider W, Krumpl G, Grohs JG, Raberger G. Arch Int Pharmacodyn Ther; 1989 Feb; 298():96-107. PubMed ID: 2757470 [Abstract] [Full Text] [Related]
13. Effects of four calcium channel blockers on central cardiovascular control. Montastruc JL, Damase-Michel C, Dang-Tran L, Montastruc P. Arch Int Pharmacodyn Ther; 1989 Feb; 297():112-9. PubMed ID: 2730230 [Abstract] [Full Text] [Related]
14. Comparative studies of the systemic hemodynamics and myocardial oxygen consumption of FRC 8653, a new Ca++ channel blocker, and nifedipine in anesthetized dogs. Chibana T, Noguchi K, Ojiri Y, Sakanashi M. Jpn Heart J; 1992 Mar; 33(2):239-52. PubMed ID: 1593752 [Abstract] [Full Text] [Related]
18. Cardiovascular activities of the new potent and long-lasting antihypertensive calcium entry blocker (+-)-3-ethyl,5-methyl,2- ([2-(formylamino)-ethyl]- thiomethyl)-6-methyl-4-(3-nitrophenyl)-1,4-dihydropyridine-3,5-dicar box ylate. Germini M, Passoni A, Casciarri I, Bosetti P, Piazzoni L, Cazzulani P, Gandolfi CA, Tofanetti O, Ceserani R. Arzneimittelforschung; 1992 Jan; 42(1):1-8. PubMed ID: 1586373 [Abstract] [Full Text] [Related]
19. Cardiohemodynamic effect of a novel calcium antagonist, SD-3211, in the dog. Takada T, Miyawaki N, Nishimura K, Nakata K, Matsuno K, Ishida N, Yamauchi H, Iso T. Arch Int Pharmacodyn Ther; 1991 Jan; 309():75-87. PubMed ID: 1888232 [Abstract] [Full Text] [Related]